VanEck Pharmaceutical ETF (PPH)

NasdaqGM

113.16
+2.08 (+1.87%)
Updated Aug 18, 5:00 PM ET
AI Rating
Hold
Overall Score
61
Trend
72
Momentum
43
Risk
68

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

VanEck Pharmaceutical ETF is trading at $113.16, up 1.87% on the session. The 50 day average sits at $108.69 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 52.6, which reads as neutral, and MACD is bearish crossover. Volume is below average.

The nearest support is around $107.70 with resistance near $111.47, so that band frames the current range. Average daily movement is roughly $1.91, or about 1.7% of the share price, which is what any stop placement has to allow for. The overall health score of 61 out of 100 combines a trend score of 72, momentum of 43 and a risk score of 68.

Technical indicators

RSI (14)
52.6
neutral
MACD
0.775
bearish crossover
SMA 20
110.69
SMA 50
108.69
SMA 200
--
unknown
ATR (14)
1.91
avg daily range
Support
107.70
Resistance
111.47
Volume vs 20d
0.62x
below average
Volatility
18.3%
annualised
1 month
+0.89%
3 months
+8.90%

About VanEck Pharmaceutical ETF

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.